首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1905119

日本肝素市場報告（按產品、來源、給藥途徑、應用、最終用戶、配銷通路和地區分類，2026-2034年）

Japan Heparin Market Report by Product, Source, Mode of Administration, Application, End User, Distribution Channel, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年日本肝素市場規模達3.587億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到6.167億美元，2026年至2034年期間的複合年成長率（CAGR）為6.21%。心血管疾病（如深部靜脈栓塞、肺栓塞、心房顫動等）病例的增加，需要抗凝血治療，是推動市場成長的主要因素。

本報告解答的關鍵問題：

日本肝素市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本肝素市場產生了哪些影響？
日本肝素市場依產品類型分類的組成是怎樣的？
日本肝素市場依來源分類的組成是怎樣的？
日本肝素市場依給藥途徑分類的組成是怎樣的？
日本肝素市場依應用領域分類的組成是怎樣的？
日本肝素市場依最終用戶分類的組成是怎樣的？
日本肝素市場依配銷通路分類的組成是怎樣的？
日本肝素市場價值鏈的各個階段有哪些？
日本肝素產業的關鍵促進因素和挑戰是什麼？
日本肝素市場的結構是怎麼樣的？主要參與者有哪些？
日本肝素市場的競爭程度如何？

Japan heparin market size reached USD 358.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 616.7 Million by 2034, exhibiting a growth rate (CAGR) of 6.21% during 2026-2034. The increasing cases of cardiovascular diseases such as deep vein thrombosis, pulmonary embolism, atrial fibrillation, etc., that require anticoagulant therapy, are driving the market.

Heparin is a widely used anticoagulant medication that helps in preventing the production of blood clots in the circulatory system. It is a naturally occurring substance found in the liver and mast cells of animals, particularly in the mucous membranes of the lungs and intestines. Heparin works by inhibiting the activity of thrombin and other clotting factors, thereby preventing the conversion of fibrinogen into fibrin, a crucial step in blood clot formation. Heparin is administered through intravenous or subcutaneous injection and is commonly employed in various medical settings, including surgeries, dialysis, and as a treatment for ailments, such as pulmonary embolism and deep vein thrombosis. It is considered a fast-acting anticoagulant and is often used in emergency situations to prevent life-threatening clots. However, its use requires careful monitoring to avoid excessive bleeding, and patients may need frequent blood tests to adjust the dosage.

Japan Heparin Market Trends:

Numerous key factors are driving the growth of the heparin market in Japan. Firstly, an aging regional population is contributing to increased demand for heparin-based therapies, as older individuals are more susceptible to conditions like deep vein thrombosis and pulmonary embolism. Additionally, the rising cases of chronic diseases such as cardiovascular disorders and cancer are bolstering the need for anticoagulant treatments like heparin. Furthermore, the rising importance of anticoagulants in managing severe cases is also creating a positive outlook for the market. Moreover, the pharmaceutical industry's ongoing R&D efforts are yielding novel formulations and delivery methods for heparin, enhancing its effectiveness and safety profile. Regulatory agencies are also playing a pivotal role in driving the market by enforcing stringent quality standards and safety regulations, which inspire confidence among healthcare professionals and patients alike. Furthermore, the escalating awareness about the benefits of heparin and its growing availability in emerging markets are fueling market expansion. Lastly, numerous advancements in medical technology and surgical procedures, which have expanded the applications of heparin, promoting its adoption in various medical settings, are expected to drive the heparin market in Japan in the coming years.

Japan Heparin Market Segmentation:

Product Insights:

Unfractionated Heparin
Low Molecular Weight Heparin (LMWH)
Ultra-Low Molecular Weight Heparin (ULMWH)

Source Insights:

Bovine
Porcine

Mode of Administration Insights:

Oral
Parenteral

Application Insights:

Atrial Fibrillation and Heart Attack
Stroke
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others

End User Insights:

Hospitals
Clinics
Homecare Settings
Ambulatory Surgical Centers
Others

Distribution Channel Insights:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan heparin market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan heparin market?
What is the breakup of the Japan heparin market on the basis of product?
What is the breakup of the Japan heparin market on the basis of source?
What is the breakup of the Japan heparin market on the basis of mode of administration?
What is the breakup of the Japan heparin market on the basis of application?
What is the breakup of the Japan heparin market on the basis of end user?
What is the breakup of the Japan heparin market on the basis of distribution channel?
What are the various stages in the value chain of the Japan heparin market?
What are the key driving factors and challenges in the Japan heparin?
What is the structure of the Japan heparin market and who are the key players?
What is the degree of competition in the Japan heparin market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Heparin Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Heparin Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Heparin Market - Breakup by Product

6.1 Unfractionated Heparin
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Low Molecular Weight Heparin (LMWH)
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Ultra-Low Molecular Weight Heparin (ULMWH)
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)

7 Japan Heparin Market - Breakup by Source

7.1 Bovine
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Porcine
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)

8 Japan Heparin Market - Breakup by Mode of Administration

8.1 Oral
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Parenteral
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)

9 Japan Heparin Market - Breakup by Application

9.1 Atrial Fibrillation and Heart Attack
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Stroke
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Deep Vein Thrombosis (DVT)
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Forecast (2026-2034)
9.4 Pulmonary Embolism (PE)
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Forecast (2026-2034)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2020-2025)
- 9.5.2 Market Forecast (2026-2034)

10 Japan Heparin Market - Breakup by End User

10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Forecast (2026-2034)
10.2 Clinics
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Forecast (2026-2034)
10.3 Homecare Settings
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Forecast (2026-2034)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Forecast (2026-2034)
10.5 Others
- 10.5.1 Historical and Current Market Trends (2020-2025)
- 10.5.2 Market Forecast (2026-2034)

11 Japan Heparin Market - Breakup by Distribution Channel

11.1 Hospital Pharmacies
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2020-2025)
- 11.1.3 Market Forecast (2026-2034)
11.2 Retail Pharmacies
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2020-2025)
- 11.2.3 Market Forecast (2026-2034)
11.3 Drug Stores
- 11.3.1 Overview
- 11.3.2 Historical and Current Market Trends (2020-2025)
- 11.3.3 Market Forecast (2026-2034)
11.4 Online Stores
- 11.4.1 Overview
- 11.4.2 Historical and Current Market Trends (2020-2025)
- 11.4.3 Market Forecast (2026-2034)
11.5 Others
- 11.5.1 Historical and Current Market Trends (2020-2025)
- 11.5.2 Market Forecast (2026-2034)

12 Japan Heparin Market - Breakup by Region

12.1 Kanto Region
- 12.1.1 Overview
- 12.1.2 Historical and Current Market Trends (2020-2025)
- 12.1.3 Market Breakup by Product
- 12.1.4 Market Breakup by Source
- 12.1.5 Market Breakup by Mode of Administration
- 12.1.6 Market Breakup by Application
- 12.1.7 Market Breakup by End User
- 12.1.8 Market Breakup by Distribution Channel
- 12.1.9 Key Players
- 12.1.10 Market Forecast (2026-2034)
12.2 Kansai/Kinki Region
- 12.2.1 Overview
- 12.2.2 Historical and Current Market Trends (2020-2025)
- 12.2.3 Market Breakup by Product
- 12.2.4 Market Breakup by Source
- 12.2.5 Market Breakup by Mode of Administration
- 12.2.6 Market Breakup by Application
- 12.2.7 Market Breakup by End User
- 12.2.8 Market Breakup by Distribution Channel
- 12.2.9 Key Players
- 12.2.10 Market Forecast (2026-2034)
12.3 Central/ Chubu Region
- 12.3.1 Overview
- 12.3.2 Historical and Current Market Trends (2020-2025)
- 12.3.3 Market Breakup by Product
- 12.3.4 Market Breakup by Source
- 12.3.5 Market Breakup by Mode of Administration
- 12.3.6 Market Breakup by Application
- 12.3.7 Market Breakup by End User
- 12.3.8 Market Breakup by Distribution Channel
- 12.3.9 Key Players
- 12.3.10 Market Forecast (2026-2034)
12.4 Kyushu-Okinawa Region
- 12.4.1 Overview
- 12.4.2 Historical and Current Market Trends (2020-2025)
- 12.4.3 Market Breakup by Product
- 12.4.4 Market Breakup by Source
- 12.4.5 Market Breakup by Mode of Administration
- 12.4.6 Market Breakup by Application
- 12.4.7 Market Breakup by End User
- 12.4.8 Market Breakup by Distribution Channel
- 12.4.9 Key Players
- 12.4.10 Market Forecast (2026-2034)
12.5 Tohoku Region
- 12.5.1 Overview
- 12.5.2 Historical and Current Market Trends (2020-2025)
- 12.5.3 Market Breakup by Product
- 12.5.4 Market Breakup by Source
- 12.5.5 Market Breakup by Mode of Administration
- 12.5.6 Market Breakup by Application
- 12.5.7 Market Breakup by End User
- 12.5.8 Market Breakup by Distribution Channel
- 12.5.9 Key Players
- 12.5.10 Market Forecast (2026-2034)
12.6 Chugoku Region
- 12.6.1 Overview
- 12.6.2 Historical and Current Market Trends (2020-2025)
- 12.6.3 Market Breakup by Product
- 12.6.4 Market Breakup by Source
- 12.6.5 Market Breakup by Mode of Administration
- 12.6.6 Market Breakup by Application
- 12.6.7 Market Breakup by End User
- 12.6.8 Market Breakup by Distribution Channel
- 12.6.9 Key Players
- 12.6.10 Market Forecast (2026-2034)
12.7 Hokkaido Region
- 12.7.1 Overview
- 12.7.2 Historical and Current Market Trends (2020-2025)
- 12.7.3 Market Breakup by Product
- 12.7.4 Market Breakup by Source
- 12.7.5 Market Breakup by Mode of Administration
- 12.7.6 Market Breakup by Application
- 12.7.7 Market Breakup by End User
- 12.7.8 Market Breakup by Distribution Channel
- 12.7.9 Key Players
- 12.7.10 Market Forecast (2026-2034)
12.8 Shikoku Region
- 12.8.1 Overview
- 12.8.2 Historical and Current Market Trends (2020-2025)
- 12.8.3 Market Breakup by Product
- 12.8.4 Market Breakup by Source
- 12.8.5 Market Breakup by Mode of Administration
- 12.8.6 Market Breakup by Application
- 12.8.7 Market Breakup by End User
- 12.8.8 Market Breakup by Distribution Channel
- 12.8.9 Key Players
- 12.8.10 Market Forecast (2026-2034)

13 Japan Heparin Market - Competitive Landscape

13.1 Overview
13.2 Market Structure
13.3 Market Player Positioning
13.4 Top Winning Strategies
13.5 Competitive Dashboard
13.6 Company Evaluation Quadrant

14 Profiles of Key Players

14.1 Company A
- 14.1.1 Business Overview
- 14.1.2 Product Portfolio
- 14.1.3 Business Strategies
- 14.1.4 SWOT Analysis
- 14.1.5 Major News and Events
14.2 Company B
- 14.2.1 Business Overview
- 14.2.2 Product Portfolio
- 14.2.3 Business Strategies
- 14.2.4 SWOT Analysis
- 14.2.5 Major News and Events
14.3 Company C
- 14.3.1 Business Overview
- 14.3.2 Product Portfolio
- 14.3.3 Business Strategies
- 14.3.4 SWOT Analysis
- 14.3.5 Major News and Events
14.4 Company D
- 14.4.1 Business Overview
- 14.4.2 Product Portfolio
- 14.4.3 Business Strategies
- 14.4.4 SWOT Analysis
- 14.4.5 Major News and Events
14.5 Company E
- 14.5.1 Business Overview
- 14.5.2 Product Portfolio
- 14.5.3 Business Strategies
- 14.5.4 SWOT Analysis
- 14.5.5 Major News and Events

15 Japan Heparin Market - Industry Analysis

15.1 Drivers, Restraints, and Opportunities
- 15.1.1 Overview
- 15.1.2 Drivers
- 15.1.3 Restraints
- 15.1.4 Opportunities
15.2 Porters Five Forces Analysis
- 15.2.1 Overview
- 15.2.2 Bargaining Power of Buyers
- 15.2.3 Bargaining Power of Suppliers
- 15.2.4 Degree of Competition
- 15.2.5 Threat of New Entrants
- 15.2.6 Threat of Substitutes
15.3 Value Chain Analysis